3 restraining orders placed on ZymoGenetics regarding Recothrom
A federal court in Tennessee granted three temporary restraining orders against ZymoGenetics, preventing it from marketing Recothrom, a drug used to control hemorrhage. The orders came after King Pharmaceuticals and three other firms filed a lawsuit accusing ZymoGenetics of unfair competition and false advertising, among other claims. In a regulatory filing, the biotech firm denied wrongdoing and said it plans to "vigorously defend" itself against the allegations.
American City Business Journals | 11/04
This story published in FDLI SmartBrief on 11/05/2009
Judge removes 3 restraining orders against ZymoGenetics
Monday, November 9, 2009
Abuse-resistant morphine Embeda gains FDA approval
Friday, August 14, 2009
Makers might wait until next year to resubmit Remoxy to FDA
Wednesday, July 8, 2009
|
FDLI SmartBrief
Designed specifically for professionals involved in the food and drug industry, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more |
|